Bloomberg: Bill Smead discusses Merck (1-31-2013)
Merck Says 2013 Profit Will Decline as Generics Cut Results By Shannon Pettypiece For more information go to www.bloomberg.com. The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of
February 4, 2013
